Patient clinical information
| Patient no. | Age (y) | Sex | Disease status | Disease stage at original diagnosis | HDI completed | Response | Duration of disease-free interval (mo) | Current status | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Clinical | Pathologic | |||||||||
| 801 | 50 | M | I | T4aN2b(cl) | 1/3DR | CR | RMiD | 32 | Deceased | |
| 803 | 42 | M | I | T4bNx | Yes | NR | RMaD | 6 | Deceased | |
| 804 | 65 | F | R | T3aN0(s) | Yes | NR | RMaD | 1 | Deceased | |
| 805 | 41 | M | R | T1bN0(cl) | Yes | PR | RMiD | 49 | NED | |
| 806 | 56 | M | R | T3a(al)N0(cl) | Yes | NR | CR | 34 | MET | |
| 807 | 66 | F | R | T3bN0(s) | Yes | NR | RMaD | 32 | NED | |
| 809 | 56 | F | I | T4bN3(cl) | Yes | NR | RMaD | 6 | Deceased | |
| 810 | 60 | M | I | T4bN2b(cl) | Yes | NR | RMaD | 6 | Deceased | |
| 811 | 72 | F | R | T3aN0(cl) | Yes | PR | RMaD | 30 | NED | |
| 812 | 76 | M | R | TxN0(s) | Yes | PR | RMaD | 15 | MET | |
| 814 | 57 | F | I | TxN3(cl) | 1/3DR | PR | RMaD | 4 | Deceased | |
| 817 | 62 | M | IP | TxN3(cl) | 1/3DR | PR | RMaD | 10 | NED | |
NOTE: Adapted from ref. 18.
Abbreviations: M, male; F, female; I, initial presentation; R, regional lymph node recurrence; IP, isolated palpable nodal metastases arising from an unknown primary; cl, nodal staging based on clinical exam; s, nodal staging based on sentinel lymph node mapping and pathologic interpretation; DR, dose reduction; CR, complete response; PR, partial response; NR, no response; RMiD, residual microscopic disease; RMaD, residual macroscopic disease; NED, no evidence of disease; MET, metastatic disease.